Halozyme, Phibro, Leidos and PDD Holdings shine as GARP picks, blending discounted valuations with strong long-term growth potential.

Halozyme, Phibro, Leidos and PDD Holdings shine as GARP picks, blending discounted valuations with strong long-term growth potential.

Broker upgrades boost Halozyme, Leidos and TransUnion, each projected for solid 2025 earnings growth and stronger returns.

StoneCo, USANA Health Sciences, KT, PagSeguro Digital and Itron stand out as undervalued picks with solid growth prospects this September.

AppLovin, Palantir, Blackstone and CrowdStrike stand out as founder-run companies with strong vision, innovation, and long-term growth drivers.

AppLovin, Palantir, Blackstone and CrowdStrike stand out as founder-run companies with strong vision, innovation, and long-term growth drivers.

OSK, EPAM, GDOT, MOS and PAGS stand out with low price-to-sales ratios, combining solid fundamentals and growth drivers to offer value in shifting...

OSK, EPAM, GDOT, MOS and PAGS stand out with low price-to-sales ratios, combining solid fundamentals and growth drivers to offer value in shifting...

Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. NVDA, RL, SFM and HWM hold promise.

Halozyme, Leidos and TransUnion earn upgraded broker ratings, with earnings growth and positive revisions boosting appeal.